Update re. St George Street Capital COVID-19 trial – Company Announcement – FT.com
03/04/25
News & Events
Investors back potential drug for diabetic Covid-19 patients
03/04/25
Clinical Study Report On Therapy To Treat Covid-19 Patients Completed (Issued on behalf of St George Street Capital and Excalibur Medicines Ltd)
21/05/24
St George Street Capital (“SGSC”) and Excalibur Medicines Limited (“EML”) are pleased to provide an update on the positive outcome of The Arcadia COVID-19 therapy Trial
21/05/24
Publication in Lancet eClinicalMedicine detailing the ARCADIA clinical trial
21/05/24